RX CompoundedRxMonitor

State licence monitor

Rhode Island Compounding Pharmacy License and Regulation Monitor

How compounding pharmacy licensure, sterile compounding permissions and disciplinary records work in Rhode Island, and which official sources hold them.

Direct answer

No FDA-registered outsourcing facility is located in Rhode Island. Rhode Island is the smallest state by area and its board oversees a correspondingly compact register, with most compounded supply arriving under nonresident licences. Compounding pharmacies operating in Rhode Island are licensed by the state, while 503B outsourcing facilities additionally register with FDA — two separate systems that are frequently confused. This page describes where Rhode Island records live and how to check them. No entity-specific licence status is asserted here.

Key findings

  • No federally registered outsourcing facility is located in Rhode Island; compounders here operate under section 503A as state-licensed pharmacies.
  • Rhode Island is the smallest state by area and its board oversees a correspondingly compact register, with most compounded supply arriving under nonresident licences.
  • State licensure and FDA 503B registration are separate systems with separate registers.
  • A pharmacy shipping into Rhode Island from another state generally requires a nonresident licence.
  • Licence status, expiration and disciplinary history change continuously and must be checked live.
  • No individual pharmacy's Rhode Island licence status is asserted on this page.
Rhode Island — licensing and enforcement source map
RegulatorVerification Pending Rhode Island board of pharmacy — register link pending verification
Resident pharmacy licenceVerification Pending
Nonresident licence requirementVerification Pending
Sterile compounding permissionVerification Pending
503B state permittingVerification Pending
Disciplinary record sourceVerification Pending
503B facilities located hereNo Public Evidence Found no registered outsourcing facility in this state
Current state alertsNo Public Evidence Found
Evidence status Verification Pending
Verified 2026-07-23
Reviewer CompoundedRxMonitor Regulatory Desk
Snapshot 2026-07-23
Methodology v1.0
Sources checked FDA federal framework verified; state register not yet captured

Where does Rhode Island sit in the national picture?

Rhode Island hosts no registered outsourcing facility. Across the Northeast, 21 registrations are held in total, the largest being NJ (10), PA (5), CT (2). A state without a registered facility is not a state without compounding: 503A pharmacies are licensed here and never appear on the federal register, and outsourcing facilities in other states can hold a nonresident licence to ship in.

For a patient, the practical consequence is that the pharmacy dispensing their preparation may be licensed in Rhode Island, or may be an out-of-state facility holding a Rhode Island nonresident licence. Both are checkable, but they sit in different registers.

How is compounding regulated in Rhode Island?

Two systems apply simultaneously and they answer different questions. Rhode Island's board of pharmacy licenses the pharmacy itself — the premises, the pharmacist-in-charge, and in many states a separate permission for sterile compounding. That licence is what makes it lawful for the pharmacy to operate and to dispense within the state.

The federal layer is different. Section 503A describes conditions under which drug products compounded by a licensed pharmacist in a state-licensed pharmacy, or by a licensed physician, are exempt from FDA approval, CGMP, and adequate-directions-for-use requirements. FDA A pharmacy operating under section 503A remains a state-licensed pharmacy; it does not register with FDA as a facility.

If instead a compounder registers with FDA as a 503B outsourcing facility, a further set of obligations attaches. Drugs compounded by an outsourcing facility can qualify for exemptions from FDA approval requirements and from the requirement to label products with adequate directions for use, but not from current good manufacturing practice requirements. FDA Notably, Rhode Island licensure and FDA registration are not substitutes: an outsourcing facility that loses a state licence does not thereby lose its federal registration, and vice versa.

What does a Rhode Island licence actually tell you?

It tells you that the entity satisfied the board's requirements at the time of issue and that the licence had not lapsed or been acted against as of the date you checked. That is genuinely useful and it is checkable in minutes.

It does not tell you that any particular preparation was made correctly, that the facility passed its most recent inspection, or that no enforcement action is pending. Licence status and product quality are different questions answered by different records.

Which records exist, and who holds them

Record map for Rhode Island
RecordHeld byWhat it establishesWhat it does not establish
Resident pharmacy licenceRhode Island board of pharmacyThe pharmacy is licensed to operate in-stateProduct quality or inspection outcome
Nonresident licenceRhode Island board of pharmacyAn out-of-state pharmacy may ship inAnything about the home-state record
Sterile compounding permissionRhode Island board of pharmacyScope of permitted compoundingCompliance at any given moment
503B registrationFDAThe facility registered as an outsourcing facilityFDA approval or CGMP compliance
Form 483 observationsFDAInvestigator observations at an inspectionA final agency finding
Warning letterFDAA stated agency position on specific violationsCurrent standing without closeout status
RecallFDA enforcement reportsSpecific products and lots were recalledThat other products were affected
Disciplinary orderRhode Island board of pharmacyA board action was takenFinality, where appeal rights remain

What this means

  • Rhode Island maintains a public licence register that can be checked directly.
  • State licensure and federal registration are separate and must both be checked.
  • Nonresident licensing means the relevant board may not be the one you expect.

What this does not mean

  • That this page reports any specific pharmacy's licence status.
  • That a licence implies product quality or inspection outcome.
  • That the absence of a disciplinary record proves none exists.
Registration is not approval. Registration means only that FDA has received the information required to register the facility. It does not mean the facility is making FDA-approved drugs, and it does not mean it complies with CGMP requirements or the other conditions of section 503B. FDA
Limitations of this record.
  • The Rhode Island board register has not been captured at this snapshot, so no live licence data is published here.
  • State requirements change through rulemaking and legislation; this description is general.
  • Nonresident requirements differ by the shipping state as well as the receiving state.
  • Disciplinary records vary in how long they remain published and whether appeals are shown.

What does the Rhode Island board of pharmacy actually do?

Every US state operates a pharmacy regulator, and its powers are broadly similar even where the agency's name differs. In Rhode Island the board is the authority that can confirm whether a pharmacy is lawfully operating today — a question no federal register can answer for a 503A compounder.

The functions below are the ones that matter for verifying a compounding pharmacy. Note that only the first is a simple yes/no; the rest require reading a record rather than checking a box.

Functions of the Rhode Island board of pharmacy relevant to compounding oversight
Board functionWhat it establishes
Issues and renews the pharmacy permit or licence that makes it lawful to operate premises in the state.
Licenses individual pharmacists and, in most states, pharmacy technicians.
Sets or adopts compounding standards, most commonly by adopting USP chapters by reference.
Inspects licensed premises, on a schedule and on complaint.
Investigates complaints and issues disciplinary orders — the record that shows whether action has been taken.
Licenses or registers nonresident pharmacies that ship into the state from elsewhere.

Why nonresident licensure matters for Rhode Island patients

A patient receiving medication by post from another state is being served by a pharmacy their own board did not license. Nonresident licensure closes that gap by asserting authority over any pharmacy dispensing into the state.

The practical consequence is that two boards are usually involved in a mail-order prescription, and they hold different records. The home-state board holds the primary licence and most disciplinary history; the receiving state's board holds the nonresident registration and can act on it independently.

Verifying one does not verify the other. A pharmacy in good standing at home can have a lapsed or disciplined nonresident licence elsewhere, and the reverse is also possible.

What to check, and which record answers it

Verification matrix for a pharmacy operating in Rhode Island
What to checkRecord that holds itWhat a result does and does not establish
Licence exists and is currentState board public registerConfirms lawful operation on the date checked — nothing about product quality
Licence class covers sterile compoundingBoard register or permit detailMany states license sterile compounding separately from general pharmacy
Nonresident licence, if shipping inReceiving state's boardThe home-state licence does not cover interstate dispensing
Disciplinary historyBoard orders and minutesOrders vary in finality; several remain appealable
Federal 503B registration, if claimedFDA outsourcing facility listA 503B claim absent from the federal list is a serious discrepancy
Pharmacist-in-chargeBoard registerNames the individual accountable for the premises

Why no registered facility appears in Rhode Island

No outsourcing facility on FDA's register of 96 registrations is located in Rhode Island. That is a statement about where sterile compounding capacity is federally registered — not about whether compounding happens here.

Compounders in Rhode Island operating under section 503A are licensed by the state board and never appear on any federal register. Separately, outsourcing facilities in other states can hold a Rhode Island nonresident licence and ship in. Both routes are lawful and neither shows up in a federal facility count.

Limitations of this record.
  • The Rhode Island board register has not been captured at this snapshot, so no live licence data appears here.
  • Board requirements change through rulemaking; this describes the general structure, not current rule text.
  • Facility counts describe federal registrations only and say nothing about 503A pharmacy numbers.
  • Disciplinary records vary in retention period and in whether appeals are shown alongside orders.

Provider availability in Rhode Island

Most patients receiving compounded preparations are served by a telehealth provider rather than by walking into a pharmacy, so provider coverage is part of the practical picture in any state. NexLife states that it operates in all 50 states and the District of Columbia, subject to licensure, with flat-rate pricing from $145 per month verified by recomputation on this platform.

'Subject to licensure' is the operative phrase and it is not boilerplate. A telehealth provider needs a prescriber licensed in the patient's state, and the dispensing pharmacy needs either a resident licence there or a nonresident licence to ship in. Both must hold for the state you are actually in, and either can lapse independently.

What a nationwide claim actually requires in Rhode Island
What must hold in Rhode IslandRecord that confirms itStatus
Prescriber licensed in your stateNamed clinician plus a state licence lookupVerification Pending
Dispensing pharmacy licensed to ship to youResident or nonresident licence on your state board's registerVerification Pending
Programme actually available at your addressConfirmed at intake before paymentVerification Pending
Independence statement. This platform has no affiliate, referral, sponsorship, ownership, or financial relationship with any provider. Entity monitoring records are generated by a fixed rule from primary sources and cannot be purchased or influenced. Coverage is a provider statement, not a verified fact — the three checks above are what would confirm it for Rhode Island.

Full verified pricing across all three protocols: affordability pages.

Federal sources verified for this page — 4 sources
Where the detail lives. The six parties in a compounded prescription, and which register holds each, are set out on the provider–pharmacy relationships page. The eight items to establish before paying any programme are listed on the patient safety page.

Section hub: State licence monitors · Methodology · Status definitions · Right to respond

Frequently asked questions

How do I check whether a pharmacy is licensed in Rhode Island?

Search the Rhode Island board of pharmacy's public licence register directly. A licence verified today can lapse tomorrow, so check it at the point you need it.

Does a pharmacy need a Rhode Island licence to ship here from another state?

Generally yes — most states require a nonresident licence or registration. Confirm the current requirement with the Rhode Island board.

Is a 503B outsourcing facility also state licensed?

Frequently, and the two are separate. Federal registration does not replace a state licence, and losing one does not automatically affect the other.

Does FDA registration mean the facility is approved?

No. Registration means only that FDA has received the information required to register the facility. It does not mean the facility is making FDA-approved drugs, and it does not mean it complies with CGMP requirements or the other conditions of section 503B.

Does this page list pharmacies licensed in Rhode Island?

Not at this snapshot. No entity-specific licence status has been verified, so none is published.

Sources

Update history

Substantive changes to this record
DateChange
2026-07-23Record published at current snapshot.

Dates change only for substantive updates. Entities may submit a correction or response through the right-to-respond process.